Jumping into the vaccine gold mine... or landmine?


In July, the government had agreed for the facilities owned by Pharmaniaga Bhd and Duopharma Biotech Bhd to be used for the fill and finish process of the Covid-19 vaccine.

THE latest buzzword in the market now is vaccine, amid all the fanfare surrounding rubber glove makers who have been enjoying a spectacular run in the coronavirus disease (Covid-19) race.

If there is something that will stop the dominance of rubber gloves in their tracks it will have to be the development of a vaccine.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

vaccine , distribution , Duopharma , NRPA , Pharmaniaga , Covid-19 ,

   

Next In Business News

Oil prices little changed as markets weigh demand against US inventories
Most Asian currencies, equities fall on US tariff, slow rate cut concerns
Malaysia aiming to become energy, chip making hub, PM says
Malaysia’s growth set to surpass 5% this year, minister says
NPC Resources major shareholders in talks for potential privatisation at RM2.82 per share
Competition in coffee chain market intensifies
Prices of landed houses in Klang Valley to rise up to 4% in 2025 - CBRE|WTW
Oil prices edge down on rising U.S. fuel inventories
Unit price index of steel down 0.1% to 4.6% in Dec 2024 - DoSM
T7 Global unit secures services contract from Hibiscus Oil

Others Also Read